Related Experiment Videos
Percutaneous transluminal angioplasty following endarterectomy
J Tisnado1, S R Cho, M C Beachley
1Department of Radiology, Medical College of Virginia, Richmond.
Insights
Percutaneous transluminal angioplasty (PTA) is a safe and effective treatment for aortoiliofemoral occlusive disease, comparable to surgery. Prior endarterectomy does not prevent successful PTA for recurrent disease.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Atherosclerosis Research
Background:
- Aortoiliofemoral atherosclerotic occlusive disease historically treated with bypass grafting or endarterectomy.
- Percutaneous transluminal angioplasty (PTA) has emerged as a primary treatment modality.
- PTA offers comparable efficacy and improved safety over surgical interventions.
Purpose of the Study:
- To evaluate the effectiveness and safety of PTA for aortoiliofemoral atherosclerotic occlusive disease.
- To compare PTA outcomes with historical surgical treatments.
- To assess the feasibility of PTA following prior endarterectomy.
Main Methods:
- Review of percutaneous transluminal angioplasty procedures for aortoiliofemoral occlusive disease.
- Comparison of arterial wall trauma and healing mechanisms between PTA and endarterectomy.
- Analysis of outcomes in patients with and without prior endarterectomy.
Main Results:
- PTA demonstrates similar arterial wall trauma and healing processes as endarterectomy.
- PTA is as effective and safer than surgical options for aortoiliofemoral disease.
- Patients with prior endarterectomy experienced comparable outcomes with subsequent PTA, with no complications.
Conclusions:
- PTA is a well-established, safe, and effective treatment for aortoiliofemoral atherosclerotic occlusive disease.
- The healing and procedural characteristics of PTA and endarterectomy are similar, allowing for sequential application.
- Prior endarterectomy does not contraindicate subsequent PTA for recurrent disease.
Abstract:
Prior to the introduction of percutaneous transluminal angioplasty (PTA), bypass grafting or endarterectomy was the treatment of choice for aortoiliofemoral atherosclerotic occlusive disease. Currently, PTA is a well-established procedure for the treatment of aortoiliofemoral atherosclerotic occlusive disease. PTA is as effective as, and safer than, surgery in these cases. Percutaneous transluminal angioplasty and endarterectomy cause similar trauma to the arterial wall, i.e., intimal denudation, plaque disruption and splitting, and medial disruption, splitting, and overstretching. Both PTA and endarterectomy heal in a similar manner, i.e., neointima formation and scarring. Both PTA and endarterectomy can be repeated. Therefore, PTA can be performed after endarterectomy or vice versa. Several patients with recurrent occlusive disease after endarterectomy have been safely treated with PTA. Our results obtained with PTA in patients who had a prior endarterectomy are comparable to the results obtained in patients who did not have a prior endarterectomy. No complications have been encountered. A previous endarterectomy does not preclude a subsequent PTA, or vice versa, in patients with recurrent occlusive disease.